Wintrust Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $240K | Sell |
598
-28
| -4% | -$11.2K | 0.21% | 81 |
|
|
2024
Q3 | $291K | Sell |
626
-5,200
| -89% | -$2.42M | 0.22% | 83 |
|
|
2024
Q2 | $2.73M | Buy |
5,826
+1,128
| +24% | +$529K | 0.22% | 87 |
|
|
2024
Q1 | $1.96M | Buy |
4,698
+2,811
| +149% | +$1.18M | 0.17% | 124 |
|
|
2023
Q4 | $768K | Buy |
1,887
+438
| +30% | +$178K | 0.07% | 217 |
|
|
2023
Q3 | $504K | Sell |
1,449
-120
| -8% | -$41.7K | 0.05% | 257 |
|
|
2023
Q2 | $552K | Buy |
+1,569
| New | +$552K | 0.06% | 257 |
|
|
2022
Q4 | – | Sell |
-3,209
| Closed | -$793K | – | 415 |
|
|
2022
Q3 | $793K | Buy |
3,209
+1,209
| +60% | +$299K | 0.1% | 166 |
|
|
2022
Q2 | $363K | Sell |
2,000
-700
| -26% | -$127K | 0.04% | 273 |
|
|
2022
Q1 | $492K | Sell |
2,700
-900
| -25% | -$164K | 0.05% | 253 |
|
|
2021
Q4 | $655K | Buy |
3,600
+2,100
| +140% | +$382K | 0.06% | 222 |
|
|
2021
Q3 | $279K | Sell |
1,500
-329
| -18% | -$61.2K | 0.04% | 227 |
|
|
2021
Q2 | $369K | Buy |
1,829
+400
| +28% | +$80.7K | 0.04% | 300 |
|
|
2021
Q1 | $307K | Buy |
+1,429
| New | +$307K | 0.03% | 324 |
|